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Background: Although meta-analyses have demonstrated that physical activity can positively impact quality of life
outcomes in early stage cancer patients, it is not yet known whether these benefits can be extended to patients
with advanced cancer. In a previous pilot survey of patients with advanced cancer with a median survival of
104 days, participants felt willing and able to participate in a physical activity intervention, and reported a strong
preference for walking and home-based programming. Here, we report on the initial development and feasibility of
a home-based functional walking program in patients with advanced cancer receiving palliative care.
Methods: Nine adult patients were recruited from outpatient palliative care clinics and palliative home care. A pilot
intervention trial was conducted over a 6-week period. The McGill Quality of Life Questionnaire (MQOL), Late Life
Function and Disability Instrument (LLFDI), Edmonton Symptom Assessment System (ESAS), Seniors Fitness Test,
four-test balance scale, and grip strength, were performed pre- and post-intervention. Participants wore activPAL™
accelerometers to monitor ambulatory activity levels.
Results: Of the nine recruited participants, three participants dropped out prior to baseline testing due to hospital
admission and feeling overwhelmed, and three participants dropped out during the intervention due to severe
symptoms. Only three participants completed the intervention program, pre- and post-intervention assessments:
two reported improvements in total MQOL scores, yet all three shared an overall trend towards worsening
symptom and total fatigue scores post-intervention. Two participants passed away within 90 days of completing
the intervention.
Conclusions: This case series demonstrates the challenges of a physical activity intervention in patients with
advanced cancer receiving palliative care. Further feasibility research is required in this patient population.
Trial registration: This study is registered under ClinicalTrials.gov as NCT00438620.
Keywords: Physical activity, Palliative care, Cancer, Quality of life, WalkingBackground
Among the most common distressing symptoms facing
patients with advanced cancer is loss of physical function
[1]. Its underlying aetiology is multifactorial, with increas-
ing fatigue, muscle wasting and generalized debility all
contributing to this phenomenon [2]. Loss of physical
function impedes the patient’s ability to perform activities
of daily living, and increases dependence on caregivers* Correspondence: Sonya.Lowe@albertahealthservices.ca
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reproduction in any medium, provided the orleading to additional emotional and psychological burden
[3]. The importance of keeping mobile is linked to
maintaining independence and overall quality of life [QoL]
in patients with advanced cancer.
Increasing attention has been given to physical activity
as a QoL intervention in cancer patients [4]. Physical
activity interventions can improve cancer-related fatigue
and physical functioning in early stage cancer patients
[5,6]; however, these benefits have not been confirmed
for patients at later stages of cancer. There is prelimi-
nary evidence that select patients with advanced cancer
express willingness to participate in a physical activitytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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care outcomes [7].
Oldervoll et al. conducted a randomized controlled trial
to examine the effects of an eight-week group exercise
program versus usual care on 231 patients with advanced
cancer with median survival of one year [8]. Analyses
revealed no significant differences between groups in the
primary endpoint of physical fatigue, however there were
improvements in the intervention group in physical per-
formance as measured by the shuttle walk and handgrip
strength tests. Oldervoll et al. earlier acknowledged that
patients who declined participation had identified limi-
tations of fatigue, lack of mobility, and the burden of
physically getting to the hospital gym where the exercise
intervention took place [9]. Oldervoll et al. concluded
that these limitations “might indicate a need for spe-
cially tailored interventions…in the form of home-based
exercises adjusted for the individual patient” [10].
No home-based physical activity program has been
validated for patients with advanced cancer receiving
palliative care. Porock et al. conducted a pilot study of
nine home hospice cancer patients who were administered
a home-based program based on the Duke Energizing
Exercise Plan, with a range of different physical activities
prescribed according to the patient’s individual condition
and tolerability; despite the trend towards increased QoL
scores, the authors concluded that the optimal type of
physical activity program for this population is still
unknown [11].
We previously completed a pilot survey of fifty pa-
tients with advanced cancer with a median survival of
104 days; 92% of participants reported that they would be
interested in and able to participate in a physical activity
program [12]. Moreover, 84% of participants indicated a
preference for a home-based individual (i.e. not group)
physical activity program. Walking and resistance train-
ing were the top two activities endorsed by these partic-
ipants, with 56% preferring to participate in up to 3
physical activity sessions per week [13].
Incorporating patient preferences is critical in design-
ing an effective intervention [14] and may enhance re-
cruitment and adherence, and potential benefits. Based
on the preferences identified in our pilot survey and
using a similar recruitment strategy, this study examined
the initial development and feasibility of a home-based
functional walking program in patients with advanced
cancer receiving palliative care.
Methods
Setting and participants
The study was conducted between July to December 2007
at the Department of Symptom Control and Palliative
Care, Cross Cancer Institute (CCI) and the Regional
Palliative Home Care program (RPHCP) in Edmonton,Canada. Participants were diagnosed with progressive,
incurable, and locally recurrent or metastatic cancer, and
were receiving palliative care. Eligibility criteria included:
1) 18 years of age or older; 2) able to understand and
speak English; 3) cognitive ability to participate (defined
as a normal Folstein’s Mini Mental State Examination
Score for patient’s age and education level [15]); and 4)
clinician-estimated life expectancy of 3 to 12 months.
Participants were ineligible if they presented with: 1)
Any absolute contraindications to physical activity [16];
and 2) Palliative Performance Scale (PPS) level of 30% or
less [17]. Eligible participants were required to read and
sign a consent form, which detailed the right to withdraw,
confidentiality, and the risks and benefits of participating
in the study.
Consent
Ethical approval for the study was received from the
Health Research Ethics Board of the University of Alberta
and the Research Ethics Committee of the Alberta Cancer
Board. Written informed consent was obtained from
the patients for publication of this case report and any
accompanying images. A copy of the written consent is
available for review.
Study design and recruitment
The study was a quasi-experimental pilot study using
pre-post test design to provide preliminary data on the
feasibility and outcomes of a six-week physical activity
program. Consecutive patients were approached by a
member of the health care team at both the RPHCP and
CCI settings, and if interested in participating, they
consented to be contacted by the study coordinator.
Physical activity intervention
The intervention was a modified home-based functional
walking program involving an individually prescribed
walking plan and combination of muscle strengthening
and balance retraining exercises [18,19]. The aerobic
component required participants to perform daily walk-
ing, with duration and intensity individually prescribed
based on the results of baseline physical function testing.
For the strength component, participants performed in-
dividualized muscle strengthening and balance retraining
exercises, three times per week on non-consecutive days
(see Additional file 1: Appendix 1). A professional exercise
therapist supervised all strength sessions in the partici-
pant’s home.
The mode, intensity (resistance) and duration of each
strength exercise were based on the results of the partic-
ipant’s baseline physical function testing. Variations on
each strength exercise were provided for increasing
levels of difficulty and to allow for individual prescrip-
tion (see Additional file 2: Appendix 2). Ankle/wrist cuff
Lowe et al. BMC Palliative Care 2013, 12:22 Page 3 of 9
http://www.biomedcentral.com/1472-684X/12/22weights and/or resistance bands were used to provide
resistance during muscle strengthening and balance
retraining exercises. Changes in number of exercises,
sets and repetitions were made with the aim to progress
to the desired exercise prescription as soon as safely
possible. Five minutes of warm up and cool down exercises
were performed before and after each strength session
(see Additional file 1: Appendix 1).Objective assessment of physical functioning
Physical functioning was measured using six basic phys-
ical function parameters associated with functional tasks
and activities that are significant in the everyday living
of older adults [20]. Balance was assessed via a four-test
balance scale [18] (see Additional file 3: Appendix 3).
Grip strength was assessed using a handheld dynamometer.
In addition to these standardized tests, the participant’s
height, weight, body mass index, blood pressure, heart rate
and oxygen saturation were measured. The study coordin-
ator performed all physical functioning measurements in
the patient’s home.
Objective assessment of physical activity
Physical activity was recorded using the activPAL™ accel-
erometer, which monitors triaxial movement in the form
of lying or sitting, quiet standing and stepping [21]. The
20 gram, 35 × 53 × 7 millimetre unit is secured to the
participant’s anterior mid-thigh using an adherent
hydrogel PALstickie™ and participants were asked to re-
move the units when bathing or showering, and replace
once the underlying skin is dried. Participants were
asked to wear the unit for one baseline week prior to ini-
tiation of the intervention, and for the 6-week duration
of the program. The activPAL™ accelerometer has been
validated in a number of clinical populations [22], and
most recently has been tested in a study of 84 patients
with thoracic cancer [23].
Survey instrument
The survey instrument was administered once at base-
line, and again post-intervention. The McGill Quality of
Life Questionnaire (MQOL) [24] was used to assess
quality of life; the MQOL has been found to be compre-
hensive, widely tested and valid across end-of-life popula-
tions [25]. Physical activity behaviour was assessed by items
drawn from the Physical Activity Scale for the Elderly
(PASE) which requires participants to recall their most
common physical activities, including frequency, intensity
and duration, performed over the past week [26]. The PASE
was developed for assessment of community-dwelling,
older adults and has been widely used and validated in vari-
ous clinical populations [27,28]. For the purposes of the
study, physical activity was defined as any bodily movementproduced by the skeletal muscles that result in a substantial
increase in energy expenditure over resting levels [29].
Patient-reported physical functioning was assessed by
the function component of the abbreviated version of the
Late-Life Function and Disability Instrument (LLFDI)
[30]; the LLFDI has been widely used and validated in
elderly populations [31].
Patient-reported symptoms were assessed using the
Edmonton Symptom Assessment System (ESAS) [32], the
Brief Fatigue Inventory (BFI), and the Hope Differential-
Short Instrument (HDS), each of which has been
respectively tested and validated in advanced cancer
populations [33-35].
Program feasibility
Program feasibility was assessed by the following: 1) recruit-
ment rate, or the number of participants accrued as a pro-
portion of those eligible, 2) retention rate, or the number of
participants completing the post-intervention assessments,
3) adherence rate, or the number of sessions attended as a
proportion of the maximum prescribed, and 4) patient
safety, or number and type of adverse events.
Results
Sample characteristics and recruitment
Accrual was stopped early due to slower than expected
accrual and higher than expected attrition. As shown by
Figure 1, 16% (10/61) of home care patients who
consented to being contacted by the study coordinator,
declined due to severe fatigue; 8% (5/61) of RPHCP pa-
tients who consented to being contacted by the study
coordinator, were recruited to the study. 30% (6/20) of
Department of Symptom Control and Palliative Care pa-
tient referrals declined due to severe fatigue; 5% (1/20)
of the remaining eligible patient referrals were recruited
to the study. 20% (3/15) of outpatient radiotherapy unit
patients who consented to being contacted by the study
coordinator, did not meet inclusion criteria for the study
because of out-of-town residence; 20% (3/15) of the
remaining eligible patients were recruited to the study.
Of the 9 patients who consented to the study, 2 partic-
ipants dropped out prior to baseline physical function
testing because of admission to hospital, and 1 partici-
pant dropped out prior to baseline physical function
testing because of feeling overwhelmed. Of the 6 pa-
tients who completed baseline physical function testing,
2 participants dropped out during Week One because of
severe dyspnoea and pain, and 1 participant dropped out
during Week Five because of terminal delirium. 3 partic-
ipants who completed baseline physical function testing,
also completed the intervention and post-intervention
assessments.
Of the 9 patients who consented to the study, the
mean age was 55 ± 5.7 years, 6/9 were female, and 5/9
Figure 1 Flow of participants through the study.
Lowe et al. BMC Palliative Care 2013, 12:22 Page 4 of 9
http://www.biomedcentral.com/1472-684X/12/22were married or common law. Gastrointestinal cancer
(n = 2), lung cancer (n = 2) and primary unknown (n = 2)
were the most common diagnoses; the remaining diag-
noses were head and neck cancer (n = 1), malignant mel-
anoma (n = 1) and anaplastic oligodendroglioma (n = 1).
7/9 had metastatic disease, with liver (n = 4) being the
most common site of metastases; 5/9 had two or more
metastatic sites concurrently. At the time of obtaining
consent, 6/9 patients had received palliative chemother-
apy. Of the 9 patients who consented to the study, the
median survival was 92 days from time of consent to
time of death.
Given that only 3 participants completed the interven-
tion and post-intervention assessments, inferential statis-
tics were not possible and all accumulated data was
reviewed descriptively. Hence the following 3 cases are
presented to review the participants who completed the
program.
Case 1
A 56 year-old man was diagnosed with cancer of un-
known primary, with metastases to the lung, liver, bone
and brain. He received a full course of palliative whole-brain radiotherapy, and daily dexamethasone was initiated.
The patient was recruited to the study post-radiotherapy,
and a summary of the participant’s baseline assessment is
provided in Table 1. His most common reported physical
activity over the past week was climbing stairs within his
home, in order to access his bedroom and bathroom on
the top floor.
The participant was prescribed a daily walking plan of
5 minutes per day at low to moderate intensity, to pro-
gress up to a total of 30 minutes per day at the end of six
weeks. All strength exercises were started at 1 set of 8 rep-
etitions, slowly progressing up to 2 sets of 8 repetitions for
most exercises. The patient was unable to progress beyond
walking 10 minutes per day before experiencing severe fa-
tigue. Modifications were made to the strength exercises,
with adoption of seated positions where possible. The par-
ticipant completed 16 out of the 18 prescribed strength
exercise sessions, and experienced no adverse events over
the course of the 6-week program.
A summary of the participant’s post-intervention as-
sessment is provided in Table 1. As monitored by the
activPAL™ accelerometer, the average number of steps
taken over the baseline week was 3714, with an average
Table 1 Outcome measures for case participants












1. MQOL Physical Symptoms (0–10) 6.0 5.5 7.2 8.3 7.0 5.0
Physical Well-Being (0–10) 7.0 6.0 9.0 9.0 5.0 4.0
Psychological (0–10) 10.0 10.0 9.4 9.3 10.0 9.5
Existential (0–10) 9.6 9.7 10.0 10.0 9.3 6.7
Support (0–10) 10.0 10.0 10.0 10.0 8.5 9.0
TOTAL SCORE (0–10) 8.5 8.2 9.1 9.3 8.0 6.8
2. LLFDI Upper Extremity Functioning (0–25) 0 9.0 5.0 0 14.0 20.0
Basic Lower Extremity Functioning (0–25) 3.0 6.0 6.5 0 5.0 14.0
Advanced Lower Extremity Functioning
(0–25)
9.0 17.0 5.0 5.0 8.0 21.0
TOTAL SCORE (0–75) 12.0 32.0 16.5 5.0 27.0 55.0
3. ESAS Pain (0–10) 2.0 2.0 0 1.0 3.0 4.0
Fatigue (0–10) 4.0 3.0 4.0 3.0 4.0 7.0
Nausea (0–10) 0.5 0 0 4.0 0 7.0
Depression (0–10) 0 0 0 0 0 0
Anxiety (0–10) 0 0 0 2.5 0 0
Drowsiness (0–10) 0 0 0 0 1.0 6.0
Appetite (0–10) 0 5.0 0 3.0 1.0 10.0
Well-Being (0–10) 0 3.0 0 2.0 2.0 4.0
Dyspnea (0–10) 0 0 0 0 1.0 3.0
4. BFI TOTAL Global Fatigue (0–10) 2.0 4.8 0.1 2.3 2.0 6.9
5. HDS Authentic Spirit Factor (1–7) 1.0 1.0 1.0 1.0 1.2 2.0
Comfort Factor (1–7) 3.3 3.3 2.5 3.3 2.0 3.5
6. Physical parameters Height (m) 1.6 1.6 1.6 1.6 1.6 1.6
Weight (kg) 158.8 150.1 84.9 82.5 59.1 60.1
BMI (kg/m2) 55.8 59.0 34.0 33.0 23.7 24.1
Resting Blood Pressure (mm Hg) 138/80 112/72 122/76 106/80 148/80 132/90
Resting Heart Rate (bpm) 86 83 93 88 84 108
7. 8-Foot up-and-go Number of seconds required 12.4 14.0 5.81 5.44 8.41 10.0
8. Chair sit-and-reach Left (number of centimeters) −30.0 −15.0 +1.0 +1.0 0 −12.0
Right (number of centimeters) −33.0 −15.0 +2.0 +2.0 0 −11.0
9. Arm curl Left (number of repetitions) 15 12 15 15 18 11
Right (number of repetitions) 16 12 13 17 14 10
10. Back scratch Left (number of centimeters) −24.0 −31.0 +2.0 +0.5 −27.0 −30.0
Right (number of centimeters) −29.0 −32.0 +3.0 +2.0 −24.5 −24.0
11. Grip strength Left (kg·feet) 32.0 34.0 24.3 24.5 34.0 25.5
Right (kg·feet) 31.8 31.8 32.0 31.0 16.0 17.0
12. 30 second chair
stand
Number of repetitions 10 8 13 17 15 11
13. Four test balance
scale
Feet together (number of seconds) 10.0 10.0 10.0 10.0 10.0 10.0
Semi-tandem (number of seconds) 10.0 10.0 10.0 10.0 10.0 10.0
Tandem (number of seconds) 10.0 0 10.0 10.0 10.0 2.0
One leg stand (number of seconds) 2.81 0 10.0 10.0 4.0 0
14. 6-minute walk Total distance (m) 264.0 162.4 467.4 488.7 320.0 250.9
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post intervention, the average number of steps taken
during Week Six was 1471, with an average estimated
total energy expenditure of 28.3 MET·hours. The major-
ity of his steps were taken inside his home. It was noted
that there was no change in dexamethasone dose over
the course of the 6-week program. The patient reported
significant total fatigue that likely impacted his endurance
and mobility. The patient expressed high satisfaction with
the physical activity program and identified one-on-one
supervision of the strength training sessions as among its
top advantages. The participant indicated that his least
enjoyed program aspect was his decline in overall condi-
tion despite participating in the physical activity program.
In follow-up, the participant passed away 77 days after
completing the study.
Case 2
A 51 year-old woman was diagnosed with lung cancer and
brain metastases. She received a full course of palliative
whole brain radiotherapy (WBRT), and daily dexametha-
sone was initiated. She was recruited from the outpatient
radiotherapy unit after completion of WBRT, and a sum-
mary of the participant’s baseline assessment is provided
in Table 1. Her most common reported physical activity
over the past week was walking approximately 30 minutes
per day, three times per week.
The participant was prescribed a daily walking plan of
10 minutes per day at low to moderate intensity, to
progress up to a total of 40 minutes per day at the end
of the six weeks. All strength exercises were started at 1
set of 8 repetitions, slowly progressing up to 2 sets of 10
repetitions for most exercises. After acquiring an upper
respiratory tract infection in Week Three, her subse-
quent dyspnoea and fatigue resulted in the delay in pro-
gression of her daily walking program to 20 minutes per
day. The participant completed 17 out of the 18 pre-
scribed strength exercise sessions.
A summary of the patient’s post-intervention assess-
ment is provided in Table 1. As monitored by the
activPAL™ accelerometer, the average number of steps
taken over the baseline week was 11,373, with an average
estimated total energy expenditure of 33.3 MET·hours;
post intervention, the average number of steps taken
during Week Six was 10,868, with an average estimated
total energy expenditure of 32.5 MET·hours. The majority
of her steps were taken outside the home. It was noted
that the participant was being slowly weaned off the dexa-
methasone over the course of the 6-week program. In
follow-up at 60 days post-intervention, the participant had
continued her daily walking regimen on her treadmill at
home, and was being considered for palliative chemo-
therapy. Overall, the participant expressed high satisfac-
tion with the physical activity program and identifiedthe home-based location as among its top advantages.
The participant indicated her preference for one-on-one
training, instead of on her own with the aid of a hand-
book or DVD.
Case 3
A 57 year-old man with hepatitis B was diagnosed with
hepatocellular carcinoma post-liver transplant with sub-
sequent liver, lung and bone metastases. He received
palliative radiotherapy to the right shoulder and thoracic
spine for bony metastatic pain. The patient was recruited
to the study post-radiotherapy, and a summary of the
patient’s baseline assessment is provided in Table 1. His
most common reported physical activity over the past
week was walking approximately 60 minutes per day, for
three times per week.
The participant was prescribed a daily walking plan of
15 minutes per day at low to moderate intensity, to
progress up to a total of 45 minutes per day at the end
of the six weeks. All strength exercises were started at 1
set of 8 repetitions, slowly progressing up to 1 set of 12
repetitions for most exercises. After receiving palliative
radiotherapy for progressive lymphadenopathy during
Week Four, the participant reported worsening nausea
and subsequent progression in his exercise prescription
was delayed. During Week Four, the participant also
exhibited increasing difficulties with balance due to
intermittent syncope, and strength exercises were
performed in the seated position where possible. The
participant completed 14 out of the 18 prescribed
strength exercise sessions.
A summary of the participant’s post-intervention as-
sessment is provided in Table 1. As monitored by the
activPAL™ accelerometer, the average number of steps
taken over the baseline week was 7232, with an average
estimated total energy expenditure of 29.1 MET·hours;
post intervention, the average number of steps taken
during Week Six was 1159, with an average estimated
total energy expenditure of 26.9 MET·hours. The majority
of his steps were taken inside the home.
Overall, the participant expressed high satisfaction
with the physical activity program and identified the
strength training component as among its top advan-
tages. In terms of negative experiences, the participant
indicated his inability to sustain the aerobic walking
component on his own given his increased symptom
burden post-radiotherapy. In follow-up, the participant
passed away 42 days after completing the study.
Discussion
The aim of this study was to examine the initial develop-
ment and pilot testing of a physical activity intervention in
patients with advanced cancer receiving palliative care.
Based on our pilot survey data, there was a majority
Lowe et al. BMC Palliative Care 2013, 12:22 Page 7 of 9
http://www.biomedcentral.com/1472-684X/12/22preference for home-based, solo interventions, with walk-
ing being the most preferred activity [13]. Therefore a
modified home-based functional walking program was
designed to incorporate the specific physical activity pref-
erences of this sample, and a similar recruitment strategy
was adopted.
There are a number of feasibility issues deserving of
attention from this study. From our pilot survey study,
we were able to recruit 50 patients over a 7 month
period [12]; using the same eligibility criteria and local
recruitment strategy, however, we were only able to
recruit 9 patients over a 6 month period. A total of 504
patients were screened through the RPHCP and CCI
outpatient radiotherapy units on behalf of all palliative
care research studies that were open for accrual during
that 6-month period, however only 15% (96/504)
consented to being contacted with regards to this
particular study (see Figure 1). In both RPHCP and CCI
settings, the first contact was such that the patient’s
interest in being contacted by the study coordinator took
precedence over obtaining physician-estimated survival;
those patients who refused, therefore, may not have ful-
filled all eligibility criteria at the time of initial screening.
Of the 96 patients who consented to being contacted
by the study coordinator, 53% (51/96) fulfilled all eligibil-
ity criteria for this study. Therefore of all patients who
consented to being contacted by the study coordinator
and who met all eligibility criteria for this study, our
accrual rate was 18% (9/51). Locally, this accrual rate is
comparable to Hutton et al.’s study of dietary intake in
151 patients with advanced cancer, wherein the authors
reported an estimated 21% accrual rate from both the
CCI and RPHCP [36]. Elsewhere, Porock et al. reported
a recruitment rate of 46% (11/24) in their pilot study of
4-week home-based exercise program in home hospice
care patients, with incomplete information as to attrition
rates and reasons for withdrawal [11]. Oldervoll et al.
reported a recruitment rate of 58% (231/400) in their
recent RCT, however the reasons behind refusal to par-
ticipate were not reported; 36% of the intervention
group, versus 23% of the control usual care group, were
lost to follow-up primarily due to disease progression
[8]. Compared to the 104-day median survival of our
pilot survey sample [12], the median survival of the 9
consented participants in this study was 92 days. It is
therefore likely that our participants were further along
the cancer trajectory than those of Oldervoll et al. [8].
Untimely attrition over a 6-week period in this popula-
tion with such limited prognosis is not unexpected [37].
From our pilot survey, the majority felt willing and
able to participate in a physical activity intervention
[13]. The ability to participate in a physical activity
program, however, may fluctuate depending on patient-
reported symptoms: 69% (35/51) of eligible patientsdeclined consent to the study because of severe symp-
toms, with fatigue being the most common reported
symptom. These findings concur with Mercadante
et al.’s prospective study of 400 palliative home care
patients with a mean survival of 52 days, wherein there
was an increase in fatigue scores over time, with a peak
in symptom intensity and frequency at the lowest levels
of Karnofsky performance status [38].
Of the 9 patients who enrolled in our study, 6/9
dropped out with the most common reason being
admission to acute care for severe symptoms. This rate
of attrition is higher when compared to large palliative
care trials; Oldervoll et al’s recent RCT reported that
36% of the intervention group, versus 23% of the control
usual care group, were lost to follow-up, primarily due
to disease progression [8]. In contrast, 5/6 dropouts
occurred within 4 weeks of starting our physical activity
intervention. Given the shorter median survival of our
pilot survey sample, consideration was given to maintain
the intervention as long as it was feasible and safe for
the patients.
Cases #1 and #2 were obese [BMI ≥ 30 kg/m2], with
the former meeting the WHO criteria for morbid obesity
[BMI ≥ 40.0 kg/m2] [39]. The relative proportion of fat
to skeletal muscle mass in these patients, however, was
not investigated. In a body composition study utilizing
computed tomography images of 111 pancreatic cancer
patients undergoing palliative treatment, 40% were over-
weight or obese, and 16% were both sarcopenic and
obese; sarcopenic obesity was shown to independently
predict survival, and was associated with poorer self-
assessed functional status [40]. Although one may postu-
late that obesity contributed to poor mobility and physical
functioning in these cases, further studies are required to
elucidate the relationship between sarcopenic obesity,
physical functioning and physical activity levels in this
population.
In all three cases, increasing symptom burden resulted
in the delay in progression in both the aerobic and
strength exercise components. There were no reported
difficulties with use of the activPAL™ or its generation of
data; the number of steps and estimated total energy
expenditure, however, decreased significantly over the
course of six weeks. Although none of the three partici-
pants achieved the target daily walking prescription, all 3
participants were able to continue both aerobic and
strength components at reduced levels. Future consider-
ation should be given to a maintenance, rather than
progressive, target daily walking prescription given the
symptom burden of this patient population.
Currently, there is no recommended minimum level of
physical activity for palliative cancer patients [41]; how-
ever any amount of physical activity that the patient can
tolerate may be better than engaging in no activity at all.
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cance in our study, wherein modifications could be
made to strength exercises without missing the entire
session completely.
On the other hand, one-on-one supervision resulted in
the exclusion of potentially eligible participants. Of the
20 eligible patients who were screened from the Depart-
ment of Symptom Control and Palliative Care and the
CCI outpatient radiotherapy units and who consented to
being contacted by the study coordinator, 35% (7/20)
were unable to participate because they lived out-of
-town. While having one-on-one supervision was identi-
fied as one of the top advantages by the three presented
case reports, the option of a self-directed intervention
by means of telehealth approaches, an instructional
handbook or video may increase accrual in future pilot
trials. Likewise, future consideration should be given to
streamlining the number of outcome assessments in view
of being less burdensome on this patient population.
Moreover, patients may recognize the difference be-
tween a one-time cross-sectional survey on physical
activity and a six-week progressive physical activity
intervention. Given that the recruitment agencies and
processes were identical, one would expect the influence
of gatekeeping to be equivalent between this study and
our previous pilot survey [12]. Taken together, our results
suggest that patients who expressed interest in the idea of
physical activity, may have encountered barriers to partici-
pating and carrying through with an actual intervention.
Eliciting patient barriers to physical activity would there-
fore be deserving of future research.
Nevertheless, improvements were noted in total MQOL
scores in two of the three cases presented. In contrast, two
of the three cases showed a decline in physical function-
ing, as demonstrated by the total LLFDI scores. All three
participants shared an overall trend towards worsening
ESAS symptom scores, and worsening total BFI global
fatigue scores post-intervention. Because of the small sam-
ple size, it is not possible to distinguish whether these ef-
fects were secondary to the physical activity program or to
progression in the underlying cancer; as shown in Headley
et al’s pilot RCT of a seated exercise program in stage IV
breast cancer patients [42], a slowing of the inevitable de-
cline in fatigue and quality of life scores may be a realistic
interventional goal which would account for the changes
seen in our case series.
Although this small sample precludes drawing conclu-
sions on intervention effects or determining sensitivity
of outcome measures, our case series provides rationale
for future feasibility studies. With respect to the local
recruitment strategy, further characterization of the
screened patient population, including exploration of
the reasons for declining consent to be contacted for
research, would aid in defining which subgroup wouldmost benefit from an intervention. Recruitment and reten-
tion may be improved by opening enrolment to advanced
cancer patients irrespective of clinician-estimated progno-
sis. Further modifications, such as shortening the duration
of the intervention, examining the effects of aerobic or
strength components separately, and including an option
for self-directed programming, may also optimize recruit-
ment and retention.
Conclusions
This case series demonstrates the challenges of actual
participation in a physical activity intervention in end
stage cancer patients. Although our pilot survey sample
reported a strong interest in physical activity, a similar
recruitment strategy for a pilot intervention yielded
higher than expected attrition and drop-outs due to
symptom severity and disease burden. Further feasibility
research is required on the role of physical activity in
patients with advanced cancer receiving palliative care.
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